PTOISBI'DBa (03-15)
`Doc code: IDS
`Approved for use through 071312016. OMB 0651-0031
`.
`.
`.
`_
`.
`.
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) FIIed
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`| 5789862
`
`
`I N
`
`IA
`
`Application Number
`Filing Date
`
`First Named Inventor
`
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`I AVN-OOQDVCNT
`
`
`
`
`
`
`
`
`U.S.PATENTS
`-
`
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code1 Issue Date
`
`Name of Patentee or Applicant
`Of cited Document
`
`Pages,ColumnS,LineS where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button.
`Add
`U.S.PATENT APPLICATION PUBLICATIONS -
`
`
`Examiner Cite No Publication
`Initial*
`Number
`
`Publication
`Kind
`Code1 Date
`
`Name of Patentee or Applicant
`Of cited Document
`
`Pages,ColumnS,LineS where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`FOREIGN PATENT DOCUMENTS
`-
`
`
`
`Pages,Columns,LineS
`
`Name of Patentee or
`
`where Relevant
`Kind
`Publication
`
`Examiner Cite Foreign Document
`Applicant of cited
`T5
`|nitia|*
`No
`Number3
`
`Code4 Date
`Passages or Relevant
`
`
`Document
`
`
`Figures Appear
`
`
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`NON-PATENT LITERATURE DOCUMENTS -
`
`
`Include name of the author (in CAPITAL LETTERS), title Of the article (when appropriate), title of the item
`T5
`(book, magazine, journal, serial, symposium, catalog, etc), date, pageS(S), volume-issue number(s),
`publisher, city and/or country where published.
`
`
`EFS Web 2.1.17
`
`

`

`
`
`
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`Application Number 15789862
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`
`mt
`I N/A
`Examiner Name
`Not Yet Assigned
`
` Attorney Docket Number
`
`
`
`
`I AVN-009DVCN7
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation regarding Time Periods 2, 3 and 4,
`5 pages, Patent Interference No. 106,013, (Doc 135), dated November 25, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation regarding Time Periods 3-4, 4
`ages, Patent Interference No. 106,007, (Doc 243), dated January 29, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation regarding Time Periods 3-4, 4
`ages, Patent Interference No. 106,008, (Doc 247), dated January 29, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation regarding Time Periods 3-4, 4
`cages, Patent Interference No. 106,013, (Doc 137), dated January 29, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation Regarding Time Periods 4—6, 4
`cages, Patent Interference No. 106,007, dated March 19, 2015 (Doc 416)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation Regarding Time Periods 4—6, 4
`cages, Patent Interference No. 106013, (Doc 151), dated March 19, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Joint Stipulation Regarding Time Periods 4—6, 4
`cages, Patent Interference No.106,008, (Doc 424 ), dated March 19, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Judgment-37 CFR § 41.127, 2 pages, Patent
`nterference No. 106,013, (Doc 197), dated September 29, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Miscellaneous Order under 37 CFR 41 .104(a), 4
`cages, Patent Interference Nos. 106,007 and 106,008, dated December 15, 2014
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Order - Authorizing Motions, Patent Interference No
`06,007, 3 pages, dated September 26, 2014 (Doc 20)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Order - Authorizing Motions, Patent Interference No
`06,007, 6 pages, dated September 23, 2014 (Doc 19)
`
`EFS Web 2.1.17
`
`

`

`
`
`
`15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|NIA
`
` Application Number
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
`(A)N
`
`4:.
`
`—l—l"NlU'i
`
`
`
`
`|AVN-009DVCN7
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Order - Authorizing Motions, Patent Interference No
`06,008, 6 pages, dated September 23, 2014 (Doc 18)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Order - Miscellaneous 37 CFR. 41 .104(a), 2
`ages, Patent Interference Nos. 106,007, 106,008, 106,013, dated November 14, 2014
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Order to Show Cause— 37 CFR§ 41 .104(a), filed in
`' atent Interference No. 106,013, June 22, 2015, pages 1—3 (Doc 193).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Redeclaration, Patent Interference No. 106,008, 2
`ages, dated September 23, 2014 (Doc 19)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Second Declaration of Matthew J. A. Wood, MD,
`I . PHIL., Patent Interference Nos. 106,007 and 106,008, 78 pages, dated February 17, 2015 (Exhibit Number 2116
`"ed in interferences 106,007 and 106,008,0n February 17, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Statement Concerning Initial Settlement
`iscussions, 3 pages, Patent Interference No. 106,013, (Doc 136), dated December 30, 2014.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Statement Concerning Subsequent Settlement
`iscussions, 3 pages, Patent Interference No. 106,007, (Doc 242), dated December 30, 2014.
`
`—l—l
`
`—l
`
`O
`
`|\J|\J
`
`—|
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Statement Concerning Subsequent Settlement
`iscussions, 3 pages, Patent Interference No. 106,008, (Doc 246), dated December 30, 2014.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, Statement Concerning Subsequent Settlement
`iscussions, filed in Patent Interference No. 106,013, August 24, 2015, pages 1—3 (Doc 195).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Austalia Response to Order to
`how Cause, filed in Patent Interference No. 106,013, July 20, 2015, pages 1—28 (Doc 194).
`
`|\JN
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List as of
`‘ pril 10, 2015, filed in Patent Interference No. 106,007, April 10, 2015, pages 1-10 (Doc 456).
`
`EFS Web 2.1.17
`
`

`

`
`
`
`15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|NIA
`
` Application Number
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List as of
`‘ pril 10, 2015, filed in Patent Interference No. 106,008, April 10, 2015, pages 1-10 (Doc 464).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List as of
`‘ pril 3, 2015, filed in Interference 106007, April 3, 2015, pages 1—10 (Doc 431).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List as of
`‘ pril 3, 2015, filed in Interference 106008, April 3, 2015, pages 1—10 (Doc 439).
`
`
`
`
`|AVN-009DVCN7 etain UWA's Benefit of AU 2004903474), 37 pages, Patent Interference No. 106,007, (Doc 394), dated February 17,
`
`|\J|\J4k00
`
`|\J0'1
`
`00|\J|\J|\J|\JO(.0CO"-40')
`
`00 _.
`
`00N
`
`0000
`
`EFS Web 2.1.17
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List as of
`‘ pril 3, 2015, filed in Interference 106013, April 3, 2015, pages 1—10 (Doc 153).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Exhibit List As of
`october 29, 2015, filed in Patent Interference No. 106,013, October 29, 2015, pages 1-10 (Doc 199).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Miscellaneous
`otion 4 (to exclude evidence), filed in Patent Interference No. 106,007, April 10, 2015, pages 1-21 (Doc 455).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Miscellaneous
`otion 4 (to exclude evidence), filed in Patent Interference No. 106,008, April 10, 2015, pages 1-21 (Doc 463).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 1
`Regarding Patentability Under 35 U.S.C. § 102/103), 38 pages, Patent Interference No. 106,007, (Doc 393), dated
`ebruary 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 1
`Regarding Patentability Under 35 U.S.C. § 102/103), 39 pages, Patent Interference No. 106,008, (Doc 402), dated
`ebruary 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 2 (To
`etain UWA's Benefit of AU 2004903474), 31 pages, Patent Interference No. 106,008, (Doc 403), dated February 17,
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 2 (To
`
`

`

`
`
`
`15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|NIA
`
` Application Number
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 3
`Regarding Patentability Under 35 U.S.C. § 101), 22 pages, Patent Interference No. 106,007, (Doc 395), dated
`ebruary 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 3
`Regarding Patentability Under 35 U.S.C. § 101), 22 pages, Patent Interference No. 106,008, (Doc 404), dated
`ebruary 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 4 (To
`eny entry of AZL's Proposed New Claims 104 and 105), 36 pages, Patent Interference No. 106,007, (Doc 397),
`ated February 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Opposition 4 (To
`eny entry of AZL's Proposed New Claims 30 and 31), 36 pages, Patent Interference No. 106,008, (Doc 405), dated
`ebruary 17, 2015
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 1 (to AZL
`Opposition 1), filed April 3, 2015 in Interference 106007, pages 1—28 (Doc 428).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 1 (to AZL
`Opposition 1), filed April 3, 2015 in Interference 106008, pages 1—28, (Doc 436).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 1 (to Maintain
`he Interference) filed April 3, 2015 in Interference 106013, pages 1—17 (Doc 152).
`
`
`
`
`|AVN-009DVCN7
`
`00000'14:
`
`000')
`
`4:-000000O(.003"-I
`4:-4:-4:-00N—‘
`
`4:.4:.
`
`EFS Web 2.1.17
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 2 (to AZL
`Opposition 2) filed April 3, 2015 in Interference 106007, pages 1-22 (Doc 429)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 2 (to AZL
`Opposition 2) filed April 3, 2015 in Interference 106008, pages 1-22 (Doc 437).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 3 (for
`udgment under 35 U.S.C. §135(b)) filed April 3, 2015 in Interference 106008, pages 1-19 (Doc 438).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 3 (to Institute
`: n Interference) filed April 3, 2015 in Interference 106007, pages 1-17 (Doc 430).
`
`

`

`
`
`
`
`Application Number 15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submrssron under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`mt
`I N/A
`
`Examiner Name
`Not Yet Assigned
`
` Attorney Docket Number
`
`
`ehearing, filed in Patent Interference No. 106,013, October 29, 2015, pages 1-20 (Doc 198).
`
`I AVN-OOQDVCNT
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 4 (To Exclude
`vidence), filed in Patent Interference No. 106,007, May 12, 2015, pages 1—13 (Doc 46?).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Reply 4 (To Exclude
`vidence), filed in Patent Interference No. 106,008, May 12, 2015, pages 1—13 (Doc 4T5).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Request for Oral
`. rgument, filed in Patent Interference No. 106,007, April 10, 2015, pages 1—4 (Doc 45?).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Request for Oral
`. rgument, filed in Patent Interference No. 106,008, April 10, 2015, pages 1—4 (Doc 465).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Request for Oral
`. rgument, filed in Patent Interference No. 106,013, April 10, 2015, pages 1—3 (Doc 190).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Request for
`
`If you wish to add additional non-patent literature document citation information please click the Add button Add
`EXAMINER SIGNATURE
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.17
`
`

`

`
`
`Application Number 15789862
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`
`mt
`I N/A
`Examiner Name
`Not Yet Assigned
`I AVN-009DVCN7
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`
`
` Attorney Docket Number
`
`
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`
` NamelPrint
`Signature
`2017—10—30
`
`
`
`

`

`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process andr'or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record 5.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.1.17
`
`